7
Participants
Start Date
January 18, 2022
Primary Completion Date
December 28, 2022
Study Completion Date
December 28, 2022
EN001
"EN001 intravenously (IV) in the treatment of Duchenne Muscular Dystrophy (DMD) Dosage for each group is as follows.~Dose group A (Low dose): 5.0x10\^5 cells/kg"
EN001
"EN001 intravenously (IV) in the treatment of Duchenne Muscular Dystrophy (DMD) Dosage for each group is as follows.~Dose group B (High dose): 2.5x10\^6 cells/kg"
Samsung Medical Center, Seoul
Lead Sponsor
ENCell
INDUSTRY